Schedule 13G ownership disclosure

Cullinan Therapeutics Inc

Security class unavailable · CUSIP: 230031106

Event date: 2022-12-31

Legacy cover-page extraction is best effort and may not include every reporting person.

Filing-level shares
3,317,544
Percent of class
7.2500%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0001085146-23-001068
Form type
SC 13G/A
Filer
CHI Advisors LLC
CIK
CIK 1791468
Filed
Feb 13, 2023
Reporting period
Dec 31, 2022
Description
Schedule 13G beneficial ownership

Explore SEC Filings Hub